Valuation: Labcorp Holdings Inc.

Market Cap 25.32B 22.61B 21.03B 19.13B 36.12B 2,450B 36.28B 253B 99.18B 1,249B 95.06B 92.99B 4,008B P/E 2026 *
22.4x
P/E 2027 * 20.2x
Enterprise Value 30.47B 27.21B 25.31B 23.02B 43.47B 2,949B 43.66B 305B 119B 1,503B 114B 112B 4,824B EV / Sales 2026 *
2.07x
EV / Sales 2027 * 1.93x
Free-Float
99.65%
Yield 2026 *
0.93%
Yield 2027 * 0.94%
1 day-0.65%
1 week+2.48%
Current month+1.31%
1 month-3.91%
3 months+12.39%
6 months+13.62%
Current year+24.42%
1 week 304.92
Extreme 304.92
318.18
1 month 302.71
Extreme 302.71
327.95
Current year 245
Extreme 245
341.8
1 year 244.52
Extreme 244.52
341.8
3 years 191.97
Extreme 191.97
341.8
5 years 191.97
Extreme 191.97
341.8
10 years 98.02
Extreme 98.02
341.8
Date Insider Type Main position Quantity % Market Cap. Importance
9/1/26 Free

Chief Technology Officer

3,000 0.0037%
9/1/26 Free

Chief Technology Officer

750 0.0009%
9/1/26 Free

EVP, COO

900 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
-0.65%+2.48%+12.48%+55.00% 25.48B
-1.87%+1.13%+12.00%+23.26% 112B
+1.37%+6.54%+5.82%+83.83% 96.35B
+2.54%-1.90%+132.85%+820.11% 56.33B
+1.84%-3.30%-10.85%+50.89% 26.23B
+0.07%-0.05%+27.69%+85.86% 25.48B
+0.26%+1.55%-16.65%-2.43% 21.32B
+1.23%+3.86%+31.57%+327.80% 20.98B
+0.44%+14.89%+14.98%+86.73% 19.83B
+0.25%+2.60%-2.47%+35.27% 17.02B
Average +0.30%+2.84%+20.74%+156.63% 42.13B
Weighted average by Cap. +0.00%+2.54%+25.38%+168.42%

Financials

2026 *2027 *
Net sales 14.75B 13.17B 12.25B 11.15B 21.04B 1,427B 21.14B 147B 57.79B 728B 55.39B 54.18B 2,335B 15.47B 13.81B 12.85B 11.69B 22.07B 1,497B 22.16B 155B 60.59B 763B 58.07B 56.81B 2,449B
Net income 1.13B 1.01B 939M 854M 1.61B 109B 1.62B 11.3B 4.43B 55.78B 4.25B 4.15B 179B 1.24B 1.11B 1.03B 939M 1.77B 120B 1.78B 12.42B 4.87B 61.29B 4.66B 4.56B 197B
Net Debt 5.15B 4.6B 4.28B 3.89B 7.35B 498B 7.38B 51.5B 20.18B 254B 19.34B 18.92B 816B 4.51B 4.03B 3.75B 3.41B 6.43B 436B 6.46B 45.08B 17.66B 222B 16.93B 16.56B 714B
Projected Income Statement - Annual - Labcorp Holdings Inc.
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Employees
-
Date Price Change Volume
26-10-09 US$312.15 -0.65% 607,847
26-10-08 US$314.20 +0.71% 703,728
26-10-07 US$311.97 +0.08% 546,618
26-10-06 US$311.71 +0.99% 987,791
26-10-05 US$308.65 +0.05% 705,911
Trader
Investor
Global
Quality
ESG MSCI
AA
Ratings Surperformance© - Labcorp Holdings Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
312.15USD
Average target price
345.12USD
Spread / Average Target
+10.56%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Labcorp Holdings Inc.